Effectiveness of Transitional Care in Inflammatory Bowel Disease; Development, Validation, and Initial Outcomes of a Transition Success Score - Takeaways - MDSpire

Effectiveness of Transitional Care in Inflammatory Bowel Disease; Development, Validation, and Initial Outcomes of a Transition Success Score

  • By

  • Martha A C van Gaalen

  • Merel van Pieterson

  • Petra Waaijenberg

  • Angelika Kindermann

  • Victorien M Wolters

  • Alie Dijkstra

  • Herbert van Wering

  • Margreet Wessels

  • Lissy de Ridder

  • Dimitris Rizopoulos

  • C Lauranne A A P Derikx

  • Johanna C Escher

  • Colitis (KiCC) Working Group for Collaborative Paediatric IBD Research in the Netherlands the Dutch Initiative on Crohn and Colitis (ICC) and Dutch Nurses Network Inflammatory Bowel Disease (NIBD) the Kids with Crohn’s

  • Patrick F van Rheenen

  • Sarah T A Teklenburg

  • Fiona D M van Schaik

  • Janneke C van der Woude

  • Jildou Hoekstra

  • Marleen de Leest

  • Carla Bakker

  • Elvira M E Besuijen-Laterveer

  • Esther Adriaanse

  • Jolien Wisse

  • Marloes Heida

  • Pamela Hurkmans

  • Nynke Boontje

  • Tessa Z Toonen

  • Wendy Heida

  • November 1, 2024

  • 0 min

Share

  • 1

    The study developed and validated a Transition Success Score (TSS) to assess transitional care effectiveness for adolescents with inflammatory bowel disease (IBD).

  • 2

    The TSS was based on the Top 10 outcome items identified through an international Delphi study involving IBD stakeholders.

  • 3

    In a multicenter study, 160 patients scored the TSS, with a mean score of 25 and 25.6% achieving the maximum score.

  • 4

    Significant associations were found between TSS scores and characteristics related to transitional care, such as knowledge and independence.

  • 5

    The TSS serves as a quantitative tool to evaluate transitional care interventions and identify IBD patients at risk during the transition to adult healthcare.

Original Source(s)

Effectiveness of Transitional Care in Inflammatory Bowel Disease; Development, Validation, and Initial Outcomes of a Transition Success Score

  • by Martha A C van Gaalen, Merel van Pieterson, Petra Waaijenberg, Angelika Kindermann, Victorien M Wolters, Alie Dijkstra, Herbert van Wering, Margreet Wessels, Lissy de Ridder, Dimitris Rizopoulos, C Lauranne A A P Derikx, Johanna C Escher, Colitis (KiCC) Working Group for Collaborative Paediatric IBD Research in the Netherlands the Dutch Initiative on Crohn and Colitis (ICC) and Dutch Nurses Network Inflammatory Bowel Disease (NIBD) the Kids with Crohn’s, Patrick F van Rheenen, Sarah T A Teklenburg, Fiona D M van Schaik, Janneke C van der Woude, Jildou Hoekstra, Marleen de Leest, Carla Bakker, Elvira M E Besuijen-Laterveer, Esther Adriaanse, Jolien Wisse, Marloes Heida, Pamela Hurkmans, Nynke Boontje, Tessa Z Toonen, Wendy Heida

  • November 1, 2024

Related Content

GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity

Pregnane X receptor (NR1I2) deficiency in mice reveals context-dependent regulation of inflammatory homeostasis

The innovation trap: How pharma weaponizes a word to extend monopolies